• Cipta Sarana Medika’s total liabilities rose 32% to IDR 163.75 billion as of September 30, 2026.
• The IDR 40.04 billion increase compared with liabilities of IDR 123.71 billion on December 31, 2025.
• The main driver was an IDR 128 billion investment credit facility from Bank Mandiri received July 29, 2026, with a 120-month tenor.
• Full settlement of Bank Syariah Indonesia’s temporary syirkah funds under musyarakah mutanaqisha financing, previously IDR 69.37 billion, partly offset the increase.
• Repayment of IDR 13.03 billion in related-party debt also offset the rise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PT Cipta Sarana Medika Tbk published the original content used to generate this news brief via Indonesia Stock Exchange (IDX) (Ref. ID: 018/Lap.Fin/CSM/X/2026) on October 30, 2026, and is solely responsible for the information contained therein.